For the quarter ending 2026-03-31, LGNZZ has $1,532,105K in assets. $534,783K in debts. $115,077K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 115,077 | 174,927 | 139,376 | |
| Short-term investments | 664,328 | 558,594 | 525,146 | |
| Accounts receivable, net | 53,383 | 59,601 | 57,560 | |
| Inventory | 13,266 | 9,126 | 11,900 | |
| Short-term portion of financial royalty assets, net | 12,151 | 22,792 | 12,416 | |
| Income taxes receivable | 1,415 | 1,446 | 536 | |
| Other current assets | 5,795 | 5,785 | 6,986 | |
| Total current assets | 865,415 | 832,271 | 753,920 | |
| Intangible assets, net | 217,341 | 225,438 | 233,535 | |
| Goodwill | 101,541 | 101,541 | 101,541 | |
| Long-term portion of financial royalty assets, net | 193,536 | 196,877 | 206,332 | |
| Noncurrent derivative assets | 13,527 | 15,632 | 9,351 | |
| Property and equipment, net | - | 3,571 | 3,466 | |
| Lease right-of-use assets | - | - | 7,609 | |
| Equity method investments | 31,515 | 46,500 | 42,000 | |
| Other investments | 87,770 | 121,451 | 106,721 | |
| Deferred income taxes, net | 8,473 | 8,345 | 9,526 | |
| Right-of-use assets | - | 7,223 | - | |
| Other | - | 1,788 | - | |
| Other assets | 12,987 | 12,582 | 2,771 | |
| Total assets | 1,532,105 | 1,560,637 | 1,476,772 | |
| Accounts payable | 5,264 | 3,238 | 3,679 | |
| Accrued liabilities | 31,845 | 31,453 | 24,084 | |
| Income taxes payable | 1,893 | 1,239 | 1,284 | |
| Current contingent liabilities | 277 | 287 | 268 | |
| Current operating lease liabilities | 1,088 | 1,095 | 1,089 | |
| Other current liabilities | 300 | 135 | 135 | |
| Total current liabilities | 40,667 | 37,447 | 30,539 | |
| Long-term deferred revenue | - | 0 | 0 | |
| Long-term contingent liabilities | 3,498 | 2,934 | 3,569 | |
| Long-term operating lease liabilities | 3,993 | 4,204 | 4,415 | |
| 2030 convertible senior notes, net | 446,896 | 446,192 | 445,493 | |
| Deferred income taxes, net | 22,614 | 36,019 | 22,673 | |
| Other long-term liabilities | 17,115 | 16,629 | 19,912 | |
| Total liabilities | 534,783 | 543,425 | 526,601 | |
| Common stock, 0.001 par value 60,000 shares authorized 20,029 and 19,774 shares issued and outstanding at march31, 2026 and december31, 2025, respectively | 20 | 20 | 20 | |
| Additional paid-in capital | 397,169 | 400,649 | 362,614 | |
| Accumulated other comprehensive income | 5,390 | 8,455 | 9,322 | |
| Retained earnings | 594,743 | 608,088 | 578,215 | |
| Total stockholders equity | 997,322 | 1,017,212 | 950,171 | |
| Total liabilities and stockholders equity | 1,532,105 | 1,560,637 | 1,476,772 | |
LIGAND PHARMACEUTICALS INC (LGNZZ)
LIGAND PHARMACEUTICALS INC (LGNZZ)